相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Suppression of pro-inflammatory adhesion molecules by PPAR-δ in human vascular endothelial cells
Yanbo Fan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis
Grant D. Barish et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis
Yasunori Takata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Activation of peroxisome proliferator-activated receptor (PPAR)δ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatly acid oxidation in moderately obese men
Ulf Riserus et al.
DIABETES (2008)
Stimulation of the peroxisome proliferator-activated receptor γ (PPARγ) and the expression of selected blood monocyte cytokine genes in diabetic macroangiopathy
Rajmund Adamiec et al.
ATHEROSCLEROSIS (2007)
Interleukin-10 is upregulated by nanomolar rosiglitazone treatment of mature dendritic cells and human CD4+T cells
Paul W. Thompson et al.
CYTOKINE (2007)
Activation of peroxisome proliferator-activated receptor-γ (PPAR-γ) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2
Yumei Ye et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Impact of oxidized low density lipoprotein on vascular cells
J Galle et al.
ATHEROSCLEROSIS (2006)
Fatty acid transduction of nitric oxide signaling - Multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands
PRS Baker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
G Pascual et al.
NATURE (2005)
A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells
S Kurebayashi et al.
ATHEROSCLEROSIS (2005)
The PPARδ agonist GW0742X reduces atherosclerosis in LDLR-/- mice
TL Graham et al.
ATHEROSCLEROSIS (2005)
Nitrolinoleic acid:: An endogenous peroxisome proliferator-activated receptor γ ligand
FJ Schopfer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
15d-PGJ2:: The anti-inflammatory prostaglandin?
JU Scher et al.
CLINICAL IMMUNOLOGY (2005)
Red cell membrane and plasma linoleic acid nitration products: Synthesis, clinical identification, and quantitation
PRS Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Transcriptional activity of peroxisome proliferator-activated receptor γ is modulated by SUMO-1 modification
T Ohshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice
L Branén et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation
S Cuzzocrea et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Peroxisome proliferator-activated receptor β/δ regulates very low density lipoprotein production and catabolism in mice on a Western diet
TE Akiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transcriptional repression of atherogenic inflammation:: Modulation by PPARδ
CH Lee et al.
SCIENCE (2003)
Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells
NP Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
PPAR activators as antiinflammatory mediators in human T lymphocytes -: Implications for atherosclerosis and transplantation-associated arteriosclerosis
N Marx et al.
CIRCULATION RESEARCH (2002)
Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors
R Cunard et al.
JOURNAL OF IMMUNOLOGY (2002)
Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages:: Role of peroxisome proliferator-activated receptor-γ
B Fischer et al.
JOURNAL OF IMMUNOLOGY (2002)
PPARγ but not PPARα ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells
BR Kwak et al.
CIRCULATION RESEARCH (2002)
Critical roles of PPARβ/δ in keratinocyte response to inflammation
NS Tan et al.
GENES & DEVELOPMENT (2001)
Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice
L Michalik et al.
JOURNAL OF CELL BIOLOGY (2001)
Anti-inflammatory mechanisms in the vascular wall
A Tedgui et al.
CIRCULATION RESEARCH (2001)
A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
WR Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Delayed activation of PPARγ by LPS and IFN-γ attenuates the oxidative burst in macrophages
A Von Knethen et al.
FASEB JOURNAL (2001)
The pleiotropic functions of peroxisome proliferator-activated receptor gamma
MB Debril et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
G Chinetti et al.
NATURE MEDICINE (2001)
Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB
SW Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis
BP Neve et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Oxidative stress interference with the nuclear factor-κB activation pathways
S Schoonbroodt et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
G Chinetti et al.
INFLAMMATION RESEARCH (2000)
Role of endocytosis in the transactivation of nuclear factor-κB by oxidized low-density lipoprotein
CY Han et al.
BIOCHEMICAL JOURNAL (2000)
Peroxisome-proliferator-activated receptor δ mediates the effects of long-chain fatty acids on post-confluent cell proliferation
C Jehl-Pietri et al.
BIOCHEMICAL JOURNAL (2000)
Peroxisome proliferator-activate inhibit development of atherosclerosis in LDL receptor-deficient mice
AC Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Lipid oxidation products in cell signaling
G Leonarduzzi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma
KH Han et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
New insights into the role of COX 2 in inflammation
DW Gilroy et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2000)
分享论文
